Company Research Report: Abu Dhabi Stem Cells Center (ADSCC)
Company Overview
- Name: Abu Dhabi Stem Cells Center (ADSCC)
- Mission of the Company: To lead groundbreaking translational research and clinical trials globally while spearheading clinical education and delivering innovative patient care tailored to the needs of the UAE and the MENA region.
- Foundation Year and Founder: Founded in 2018 to meet the growing demand for highly specialized medical services and treatments.
- Key People in the Company:
- Prof. Yendry Ventura, Chief Executive Officer
- Dr. Fatima Al Kaabi, Executive Director, Abu Dhabi Bone Marrow Transplant Program
- Headquarters: Mahdar Qutouf Street, Rowdhat, Abu Dhabi, UAE
- Number of Employees: No information is available.
- Revenue: No information is available.
- What the Company is Known For: ADSCC is known for its specialization in advanced stem cell therapy, research, and regenerative medicine. It offers a range of innovative services including autologous and allogeneic hematopoietic stem cells transplant (HSCT) for both adults and children in the UAE.
Products
- Stem Cell Services:
- Accessible hematopoietic stem cell transplantation (HSCT).
- Regenerative treatments for orthopedic, wellness, cosmetic, and anti-aging needs.
- UAECell19 for long-COVID and smokers.
- AD-BMT© Program:
- Comprehensive auto and allogeneic stem cell transplant programs.
- CAR-T Cell Engineering:
- Advanced tailored cell therapy for complex diseases.
- Regenerative Medicine:
- Focus on body's natural rejuvenation capabilities.
Key Features of Products:
- Use of cutting-edge technology and research in stem cell therapy.
- Patient-centered, holistic approach integrating clinical care, research, and education.
- In-house capabilities from basic research to clinical application, ensuring comprehensive treatment.
Recent Developments
- New Products Launched:
- Launch of Adult Stem Cell Banking in September 2023.
- UAE’s 1st CAR-T Cell Manufacturing for a pediatric leukemia case.
- New Features Added:
- No information is available.
- Partnerships and Collaborations:
- Collaborated with Vertex Pharmaceuticals for CRISPR-Cas9 gene therapy introduction in the UAE.
- Strategic collaborations with US-based organizations like Precigen and Boston Children's Hospital for various programs, including UltraCar-T technology and educational initiatives.
- Other Developments:
- Hosted the 2nd Annual Bone Marrow Transplant & Cellular Therapy Congress in October 2024.
- Received Foundation for the Accreditation of Cellular Therapy (FACT) accreditation in 2024.
Conclusion
Abu Dhabi Stem Cells Center is characterized by its pioneering role in stem cell and regenerative medicine. It incorporates a comprehensive model of healthcare, cutting-edge research, and education with a robust strategic partnership network to advance treatment solutions globally. While specific financial data is not disclosed, its global engagements and accreditation highlight its commitment to being a pioneering healthcare entity in the UAE and beyond.
